@misc{indiciaee14c0270447d,
  title = {Improving the preclinical and clinical success rates of LMW drugs depends on radical revisions to the status quo scientific foundations of medicinal chemistry: a case study on COVID Mpro inhibition},
  author = {Pearlstein, R. A. and Wan, H. and Williams, S.},
  year = {2022},
  doi = {10.1101/2022.10.31.514572},
  url = {https://www.biorxiv.org/content/10.1101/2022.10.31.514572v1},
  note = {Source identifier: 10.1101/2022.10.31.514572}
}